CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma
暂无分享,去创建一个
Max A. Horlbeck | Brian V Lien | Hugh E. Olsen | J. Weissman | M. Monje | K. Seo | E. Ullian | D. Lim | Daniel He | Miten Jain | M. Akeson | D. Raleigh | S. Liu | Harjus S. Birk | M. Malatesta | Parna Saha | N. Gupta | Mark Koontz | S. Hong | Shivani S. Thombare | Leslie Pedraza | Sung Jun Hong
[1] Hans Clevers,et al. Cancer modeling meets human organoid technology , 2019, Science.
[2] Sean K. Simmons,et al. Individual brain organoids reproducibly form cell diversity of the human cerebral cortex , 2019, Nature.
[3] Joshua M. Korn,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[4] Emanuel J. V. Gonçalves,et al. Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens , 2019, Nature.
[5] H. Fine,et al. Modeling Patient-Derived Glioblastoma with Cerebral Organoids. , 2019, Cell reports.
[6] Mark Gerstein,et al. GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..
[7] Chiara Sabatti,et al. Organoid Modeling of the Tumor Immune Microenvironment , 2018, Cell.
[8] P. Tran,et al. Clinical Development of Novel Drug–Radiotherapy Combinations , 2018, Clinical Cancer Research.
[9] Ying Liu,et al. Genome-wide screening for functional long noncoding RNAs in human cells by Cas9 targeting of splice sites , 2018, Nature Biotechnology.
[10] D. Haas-Kogan,et al. Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience , 2018, Journal of Neuro-Oncology.
[11] Ji-Yong Um,et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations , 2018, Nature.
[12] Samira Kiani,et al. An enhanced CRISPR repressor for targeted mammalian gene regulation , 2018, Nature Methods.
[13] J. Bagley,et al. Genetically engineered cerebral organoids model brain tumour formation , 2018, Nature Methods.
[14] Michael S. Fernandopulle,et al. Transcription Factor–Mediated Differentiation of Human iPSCs into Neurons , 2018, Current protocols in cell biology.
[15] Howard Y. Chang,et al. Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element , 2018, Cell.
[16] Tracy T Batchelor,et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq , 2018, Science.
[17] A. Kriegstein,et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment , 2017, Genome Biology.
[18] D. Rowitch,et al. Systematic Three-Dimensional Coculture Rapidly Recapitulates Interactions between Human Neurons and Astrocytes , 2017, Stem cell reports.
[19] Sheng Ding,et al. Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening , 2017, Stem cell reports.
[20] Spyros Darmanis,et al. Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells , 2017, Neuron.
[21] K. Schoch,et al. Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases , 2017, Neuron.
[22] Jordan A. Ramilowski,et al. An atlas of human long non-coding RNAs with accurate 5′ ends , 2017, Nature.
[23] Eric S. Lander,et al. Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras , 2017, Cell.
[24] Mariella G. Filbin,et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq , 2017, Science.
[25] Howard Y. Chang,et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells , 2017, Science.
[26] Zhongzheng Cao,et al. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR–Cas9 library , 2016, Nature Biotechnology.
[27] P. Arlotta,et al. The promises and challenges of human brain organoids as models of neuropsychiatric disease , 2016, Nature Medicine.
[28] Richard A. Adams,et al. Clinical development of new drug–radiotherapy combinations , 2016, Nature Reviews Clinical Oncology.
[29] Max A. Horlbeck,et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation , 2016, eLife.
[30] J. Soulier,et al. A nonsense mutation in the DNA repair factor Hebo causes mild bone marrow failure and microcephaly , 2016, The Journal of experimental medicine.
[31] David W. Nauen,et al. Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure , 2016, Cell.
[32] Max A. Horlbeck,et al. Single-cell analysis of long non-coding RNAs in the developing human neocortex , 2016, Genome Biology.
[33] Howard Y. Chang,et al. Long Noncoding RNAs in Cancer Pathways. , 2016, Cancer cell.
[34] Jacqueline Montes,et al. Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy , 2016, Neurology.
[35] M. Behlke,et al. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides , 2015, Nucleic acids research.
[36] D. Durocher,et al. High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.
[37] Timothy C Ryken,et al. Toward precision medicine in glioblastoma: the promise and the challenges. , 2015, Neuro-oncology.
[38] Hayley E. Francies,et al. Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.
[39] D. Rowitch,et al. Dysregulation of astrocyte extracellular signaling in Costello syndrome , 2015, Science Translational Medicine.
[40] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[41] Alexandro E. Trevino,et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.
[42] S. Dhanasekaran,et al. The landscape of long noncoding RNAs in the human transcriptome , 2015, Nature Genetics.
[43] A. Beaudet,et al. Towards a therapy for Angelman syndrome by reduction of a long non-coding RNA , 2014, Nature.
[44] J. Raizer,et al. Current Understanding and Treatment of Gliomas , 2015 .
[45] Max A. Horlbeck,et al. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.
[46] Amal Refaat,et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[47] V. Plagnol,et al. ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function. , 2014, American journal of human genetics.
[48] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[49] E. Lander,et al. Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.
[50] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[51] M. Eiraku,et al. Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell–derived neocortex , 2013, Proceedings of the National Academy of Sciences.
[52] L. Deangelis,et al. Glioblastoma and other malignant gliomas: a clinical review. , 2013, JAMA.
[53] Madeline A. Lancaster,et al. Cerebral organoids model human brain development and microcephaly , 2013, Nature.
[54] Luke A. Gilbert,et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.
[55] E. Chen,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[56] Luke A. Gilbert,et al. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.
[57] Michael T. McManus,et al. A Systematic Mammalian Genetic Interaction Map Reveals Pathways Underlying Ricin Susceptibility , 2013, Cell.
[58] Patrick Y. Muller,et al. The determination and interpretation of the therapeutic index in drug development , 2012, Nature Reviews Drug Discovery.
[59] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[60] David H Rowitch,et al. Astrocytes and disease: a neurodevelopmental perspective. , 2012, Genes & development.
[61] Cole Trapnell,et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.
[62] B. Telfer,et al. Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft , 2011, Molecular Cancer Therapeutics.
[63] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[64] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[65] Howard Y. Chang,et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.
[66] T. Halazonetis,et al. Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.
[67] M. Sofroniew,et al. Astrocytes: biology and pathology , 2009, Acta Neuropathologica.
[68] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[69] D. Hargrave,et al. Diffuse brainstem glioma in children: critical review of clinical trials. , 2006, The Lancet. Oncology.
[70] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[71] B. Scheithauer,et al. The results of radiotherapy for brainstem tumors , 1998, Journal of Neuro-Oncology.
[72] Michael Thomas,et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.
[73] T. DeWeese,et al. Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. , 2003, Cancer research.
[74] K. Aldape,et al. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.
[75] Patrick T. Reilly,et al. Loss of HCF-1–Chromatin Association Precedes Temperature-Induced Growth Arrest of tsBN67 Cells , 2001, Molecular and Cellular Biology.